Exclusive

Publication

Byline

Location

US Patent Issued to Helsinn Healthcare on July 28 for "Liquid oral formulations of netupitant and palonosetron" (Italian, Swiss Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,060, issued on July 28, was assigned to Helsinn Healthcare SA (Lugano, Switzerland). "Liquid oral formulations of netupitant and palonosetr... Read More


US Patent Issued on July 28 for "Caffeine-free ready-to-drink composition for pre-caffeine cognitive priming" (Pennsylvania Inventor)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,061, issued on July 28. "Caffeine-free ready-to-drink composition for pre-caffeine cognitive priming" was invented by Michael Hanlon (Canon... Read More


US Patent Issued to Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche Medicale, Nantes Universite on July 28 for "Dynamic covalent hydrogels, precursors thereof and uses thereof" (French Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,062, issued on July 28, was assigned to Centre National de la Recherche Scientifique (Paris), Institut National de la Sante et de la Recherc... Read More


US Patent Issued to GRIN Therapeutics on July 28 for "Methods of using radiprodil in the treatment of disorders" (Belgian, American Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,063, issued on July 28, was assigned to GRIN Therapeutics Inc. (New York). "Methods of using radiprodil in the treatment of disorders" was ... Read More


US Patent Issued to Cila Therapeutics on July 28 for "Inhalable therapeutic agent" (Massachusetts Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,064, issued on July 28, was assigned to Cila Therapeutics Inc. (Jamaica Plain, Morocco). "Inhalable therapeutic agent" was invented by Denn... Read More


US Patent Issued to NanoTech Pharma on July 28 for "Liposome formulations for treatment of cancers and drug resistance of cancers" (New Jersey Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,065, issued on July 28, was assigned to NanoTech Pharma Inc. (Hillsborough, N.J.). "Liposome formulations for treatment of cancers and drug... Read More


US Patent Issued to HANGZHOU NORMAL UNIVERSITY on July 28 for "Dual-targeting biomimetic liposome with elemene (ELE) and cabazitaxel (CTX), and preparation method and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,066, issued on July 28, was assigned to HANGZHOU NORMAL UNIVERSITY (Hangzhou, China). "Dual-targeting biomimetic liposome with elemene (ELE... Read More


US Patent Issued to CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC), NANOMOL TECHNOLOGIES, LEANBIO on July 28 for "Liposomes and its use for enzyme delivery" (Spanish Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,067, issued on July 28, was assigned to CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC) (Madrid), NANOMOL TECHNOLOGIES S.L. (Cerdanyo... Read More


US Patent Issued to Sun Vax mRNA Therapeutics on July 28 for "Modular lipid compounds and two- to three-component lipid nanoparticle compositions" (Massachusetts Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,068, issued on July 28, was assigned to Sun Vax mRNA Therapeutics Inc. (Beverly, Mass.). "Modular lipid compounds and two- to three-compone... Read More


US Patent Issued to Koranex Capital on July 28 for "Synthetic glycolipids and glycoliposome compositions : suitable for cargo delivery to the central nervous system" (Canadian, French Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,069, issued on July 28, was assigned to Koranex Capital (Montreal). "Synthetic glycolipids and glycoliposome compositions : suitable for ca... Read More